Key takeaways
- At studied oral doses (900–1,500 mg/day), berberine is generally well tolerated; digestive upset is the most common side effect.
- Berberine must be avoided in pregnancy, breastfeeding and by infants and children because it can displace bilirubin.
- Berberine inhibits liver enzymes that process many drugs and raised cyclosporine levels in transplant patients.
- Long-term safety beyond about a year is poorly studied. For patches, systemic exposure is unknown, so the same cautions apply.
For most healthy adults, short-term oral berberine at studied doses appears reasonably well tolerated; the common side effects are digestive. Berberine is not safe in pregnancy, breastfeeding or infancy, because it can displace bilirubin, and it interacts with medicines processed by several liver enzymes, including cyclosporine. Long-term safety data are limited. If you take any medication, ask a pharmacist first.
Is berberine safe for most adults?
Generally yes, at studied doses and durations. Trials have given 900–1,500 mg a day for weeks to months. The largest, a 1,108-person trial for colorectal polyp prevention, gave 0.3 g twice daily and was conducted over years of follow-up.6 Serious adverse events have been uncommon in published trials, though the overall quality of the evidence base is uneven: of 54 systematic reviews, only one was rated high quality.7
What are the most common side effects?
Digestive: constipation, diarrhoea, cramping, gas and nausea. A 2008 pilot comparing berberine with metformin reported transient gastrointestinal effects.4 Splitting the daily dose and taking it with meals is the usual advice in trials.
Is berberine safe during pregnancy or breastfeeding?
No. Berberine can cross the placenta and pass into breast milk, and it displaces bilirubin from albumin, a mechanism linked to kernicterus (bilirubin-related brain injury) risk in jaundiced newborns. Berberine-containing herbs are considered likely unsafe for infants and may be unsafe in pregnancy and breastfeeding.1 That caution applies to every form, including patches.
Can berberine harm your liver or kidneys?
Berberine hasn’t been convincingly linked to liver injury at studied doses. It does concentrate in the liver (about 70 times plasma levels in rats)5 and alters how the liver processes medicines, so anyone with liver or kidney disease should involve a clinician.
Who should not take berberine?
| Situation | Why | What to do |
|---|---|---|
| Pregnant, trying to conceive, breastfeeding | Bilirubin displacement; newborn risk | Avoid all forms |
| Infants, children, teens | Not studied; newborn risk | Avoid |
| Taking cyclosporine or transplant drugs | Raised drug levels documented | Avoid unless your specialist approves |
| Taking diabetes medicines (incl. metformin, insulin) | Additive glucose-lowering, hypoglycaemia | Only with your clinician |
| Taking drugs processed by CYP3A4, CYP2D6, CYP2C9 | Enzyme inhibition3 | Ask a pharmacist |
| Blood thinners, sedatives, blood-pressure drugs | Possible interactions | Ask a pharmacist |
| Liver or kidney disease | Altered processing | Ask your clinician |
See the full list in Berberine and medications.
Is it safe long term?
We don’t know well. Most trials last 8 weeks to a year, and few track safety beyond that. Treat indefinite daily use as unstudied.
Does any of this apply to patches?
Partly. A patch puts nothing through the stomach, so digestive side effects are unlikely; its main risk is a skin reaction where it’s worn. But no one has measured how much berberine a patch delivers into the body, so the cautious position, and ours, is to apply oral-berberine warnings to patches too. Berberine is also a photosensitiser in laboratory tests, so keep patch sites out of direct sun. Details in Berberine patch side effects.
Our approach at Norrapharm
The Berberine Patch is a topical cosmetic for adults, with warnings published up front on our safety page: not for pregnancy, breastfeeding or under-18s; talk to your doctor if you take medication; patch-test first; sleeve down in the sun. We don’t claim it treats or prevents anything, and nobody should change a medicine because they use it. For the science behind the cautions, see our research library.
Frequently asked questions
Who should not take berberine?
People who are pregnant, trying to conceive or breastfeeding; infants and children; people taking medicines processed by the CYP3A4, CYP2D6 or CYP2C9 enzymes or cyclosporine, unless a clinician approves; and people on diabetes medicines without medical supervision, because of low-blood-sugar risk.
Is berberine bad for your liver?
Berberine hasn't been convincingly linked to liver injury at studied doses, and in rats it concentrates in the liver. Because it changes how the liver processes medicines, people with liver disease or on multiple drugs should check with a clinician first.
Can you take berberine every day?
Human trials gave it daily for weeks to months, mostly up to about a year. Long-term daily safety beyond that is poorly studied.
Are berberine patches safer than pills?
They avoid digestive side effects, and their main risk is skin irritation. But how much berberine a patch delivers into the body is unknown, so pregnancy and medication cautions should be treated as applying to patches too.
Norrapharm Editorial. Norrapharm makes berberine skin patches. This guide is written by our editorial team under our editorial standards. We don’t claim our patch causes weight loss or treats any condition.
Sources
- NIH NCCIH. Goldenseal: safety. www.nccih.nih.gov/health/goldenseal
- NIH NCCIH. Berberine and weight loss: what you need to know. www.nccih.nih.gov/health/berberine-and-weight-loss-what-you-need-to-know
- Guo Y et al. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol. 2012. pubmed.ncbi.nlm.nih.gov/21870106/
- Yin J et al. Berberine vs metformin pilot; GI effects. Metabolism. 2008. pubmed.ncbi.nlm.nih.gov/18442638/
- Liu YT et al. Low oral bioavailability of berberine; liver concentration in rats. 2010. pubmed.ncbi.nlm.nih.gov/20634337/
- Chen YX et al. Berberine for colorectal adenoma prevention, 1,108-person RCT. Lancet Gastroenterol Hepatol. 2020. pubmed.ncbi.nlm.nih.gov/31926918/
- Shi et al. Overview of 54 systematic reviews of berberine. 2025. pubmed.ncbi.nlm.nih.gov/40269802/